These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2776819)

  • 1. The pharmacokinetics of ceftriaxone and cefotaxime in cirrhotic patients with ascites.
    Hary L; Andrejak M; Leleu S; Orfila J; Capron JP
    Eur J Clin Pharmacol; 1989; 36(6):613-6. PubMed ID: 2776819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics of cefotaxime in cirrhotic patients with or without ascites].
    Vincent P; Colombel JF; Husson MO; Izard D; Paris JC; Leclerc H
    Presse Med; 1988 Dec; 17(44):2331-4. PubMed ID: 2974968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and ascitic fluid penetration of piperacillin in cirrhosis.
    Hary L; Smail A; Ducroix JP; Baillet J; Andrejak M
    Fundam Clin Pharmacol; 1991; 5(9):789-95. PubMed ID: 1794834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of ceftriaxone and its relation to concentrations in extravascular compartments. Comparison with cefotaxime.
    Regamey C
    Chemotherapy; 1985; 31(2):85-94. PubMed ID: 3987394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of cimetidine in ascitic cirrhotics].
    Albin H; Couzigou P; Vinçon G; Péhourcq F; Fleury B; Béraud C
    Gastroenterol Clin Biol; 1983 Mar; 7(3):251-5. PubMed ID: 6852412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of ceftriaxone in rat: application of a pharmacokinetic-protein binding model and comparison with cefotaxime.
    Hakim L; Bourne DW; Triggs EJ
    Xenobiotica; 1989 Aug; 19(8):815-22. PubMed ID: 2815824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma-to-ascitic fluid transport rate of albumin in patients with decompensated cirrhosis. Relation to intraperitoneal albumin.
    Henriksen JH; Ring-Larsen H; Lassen NA; Parving HH; Winkler K
    Clin Physiol; 1983 Oct; 3(5):423-31. PubMed ID: 6685594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum protein binding and extravascular diffusion of methoxyimino cephalosporins. Time courses of free and total concentrations of cefotaxime and ceftriaxone in serum and pleural exudate.
    Scaglione F; Raichi M; Fraschini F
    J Antimicrob Chemother; 1990 Sep; 26 Suppl A():1-10. PubMed ID: 2228838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis.
    Tuncer I; Topcu N; Durmus A; Turkdogan MK
    Hepatogastroenterology; 2003; 50(53):1426-30. PubMed ID: 14571754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration of cefoperazone into ascites.
    Van Gossum A; Quenon M; Van Gossum M; Herchuelz A; Thys JP
    Eur J Clin Pharmacol; 1989; 37(6):577-80. PubMed ID: 2612553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral pharmacokinetics and ascitic fluid penetration of ofloxacin in cirrhosis.
    Silvain C; Bouquet S; Breux JP; Becq-Giraudon B; Beauchant M
    Eur J Clin Pharmacol; 1989; 37(3):261-5. PubMed ID: 2612541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraabdominal pressure and resorption of ascites in decompensated liver cirrhosis.
    Buhac I; Flesh L; Kishore R
    J Lab Clin Med; 1984 Aug; 104(2):264-70. PubMed ID: 6747442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftriaxone versus cefotaxime in the treatment of septicemia in adults.
    Ferencz A; Prinz G; Szalka A; Ban E
    Chemotherapy; 1989; 35 Suppl 2():5-9. PubMed ID: 2612239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of famotidine in patients with cirrhosis and ascites.
    Vinçon G; Baldit C; Couzigou P; Demotes-Mainard F; Elouaer-Blanc L; Bannwarth B; Begaud B
    Eur J Clin Pharmacol; 1992; 43(5):559-62. PubMed ID: 1483496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potencies of ceftriaxone and cefotaxime in a single chamber pharmacokinetic system simulating their in vivo half-lives.
    Unowsky J; Sattler J; Patel IH
    Chemotherapy; 1989; 35(5):338-44. PubMed ID: 2676404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on the relationship between pharmacokinetics and antibacterial activity: comparison between ceftriaxone and cefotaxime within the respiratory tract.
    Fraschini F; Scaglione F
    Chemotherapy; 1989; 35(2):77-82. PubMed ID: 2758870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of third-generation cephalosporins into human peritoneal tissue.
    Berger SA; Dan M; Serour F; Gorea A; Levenberg A; Krispin M
    Chemotherapy; 1989; 35(5):326-9. PubMed ID: 2676403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ceftriaxone in patients with renal and liver insufficiency and correlations with a physiologic nonlinear protein binding model.
    Stoeckel K; Koup JR
    Am J Med; 1984 Oct; 77(4C):26-32. PubMed ID: 6093514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefotaxime concentrations in ascites.
    Moreau L; Durand H; Biclet P
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():121-2. PubMed ID: 6252141
    [No Abstract]   [Full Text] [Related]  

  • 20. [Zinc in patients with ascites].
    Gil Extremera B; Maldonado Martín A; Ruiz Martínez M; Bermúdez García JM; Muñoz Torres F; Maldonado Martín I
    An Med Interna; 1989 Dec; 6(12):624-8. PubMed ID: 2562368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.